Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.

Skip to main content
Fig. 2 | BMC Genomic Data

Fig. 2

From: Construction and validation of a fatty acid metabolism risk signature for predicting prognosis in acute myeloid leukemia

Fig. 2

Prognostic value of the fatty acid metabolism signature in AML. A Survival outcome analysis of FA score distribution in training and validation cohort. B Kaplan-Meier analysis revealed the signature expressed prognostic value of AML in training and validation cohort (with log-rank test). C The time-dependent ROC curves showed the sensitivity and specificity of predicting 1-, 2- and 3-year overall survival according to the signature in training and validation cohort

Back to article page